• Sars Wars returns

    Allan Greenblo looks at the leadership concerns around the 'Twin Peaks' regulatory model.

  • Inside Labour

    When unions later this year start to demand double digit pay rises, don't be surprised, says Terry Bell.

  • Anti-nuclear group

    ANC general secretary Gwede Mantashe rebukes those who feel SA can't afford nuclear power.

All data is delayed
Loading...
See More

Aspen finalises GSK deal for £164m

Dec 03 2012 08:22
Reuters

Shutterstock

Company Data

ASPEN PHARMACARE HOLDINGS LIMITED [JSE:APN]

Last traded 252
Change -3
% Change -1
Cumulative volume 1545258
Market cap 0

Last Updated: 05-02-2016 at 05:00. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Aspen boosts profit, Asian unit robust

Aspen buys GSK Aussie drugs for R2.2bn

Aspen unit to buy drug portfolio from GSK

Aspen prepared to help bridge ARV shortages

Aspen buys GSK brands

Aspen: Earning to between rise 18%-24%

 

Johannesburg - Aspen Pharmacare Holdings [JSE:APN] said on Monday it has finalised the acquisition of medicines from GlaxoSmithKline for £163.8m.

The deal, announced in August, was initially pegged at £172m.

 

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.
 

Company Snapshot

We're talking about:

SMALL BUSINESS

Marketing is a big concern in SA's small business community, followed by a lack of confidence and partnering with the wrong people, according to a survey.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

The regulation of WhatsApp and other OTTs is:

Previous results · Suggest a vote

Loading...